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Some plant polysaccharides are well known to possess immunostimulatory effects. Aloe vera 
possesses confirmed curative or healing actions. The aim of this study was to evaluate the effect of the 
administration of A. vera plant extract on cellular and humoral immune response in rabbits. 20 healthy 
male New Zealand white rabbits were randomly divided into five treatment groups: Groups consisted of: 
1) control group (normal saline); 2) A. vera control; 3) vaccine control; 4) 50 mg A. vera extract + 
vaccine; 5) 150 mg A. vera extract + vaccine. The used vaccine was for myxomatosis. Blood samples 





frequency and serum immunoglobulin concentrations were evaluated. According to the results, oral 
administration of A. vera affected the composition of lymphocyte subsets and serum immunoglobulins 
positively. These findings demonstrated that A. vera may stimulate both cellular and humoral immune 
responses after immunization. 
 





Immuno-stimulants are widely used for health 
management in animals (Pugh et al., 2001). Some plant 
polysaccharides are well known to possess immuno-
stimulatory effects (Pugh et al., 2001; Im et al., 2005; Qiu 
et al., 2000). Aloe vera possesses confirmed curative or 
healing actions. A total of 360 A. vera species (commonly 
known as A. vera) are grown in the dry regions of North 
America, Europe and Asia. It is consumed both as a 
vegetable and as a traditional Chinese medicine in single 
and compounded prescriptions for treating fever, consti-
pation and ringworm. Some specially prepared A. vera 
extracts possess many biological activities such as anti-
inflammation, anti-cancer, antioxidant, anti-diabetes and 
macrophage activation (Grover et al., 2002; Krishnan, 
2006; Xiao et al., 2007; Xu et al., 2008). Polysaccharide 
with biological response modifiers derived from A. vera 
are mainly mannose polymers (Leung et al., 2004). A. 
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been well documented for years. Especially, these products 
have been extensively studied for their immunological 
effects (Yates et al., 1992; Im et al., 2005).  
Administration of A. vera has been universally demon-
strated to result in marked increase in phagocytic and 
proliferative activity of the reticuloendothelial system 
(Hanaue et al., 1989; Im et al., 2005). These products 
can modulate and stimulate both humoral and cellular 
immunity and also stimulate proliferation of murine pluri-
potent hematopoietic stem cells, granulocyte macrophage 
colony-forming cells, and cells forming myeloid and 
erythroid colonies (Egger et al., 1996; Im et al., 2005; 
Boudreau and Beland, 2006). It is demonstrated that 
immunomodulating and/or immunostimulating effects of 
these products are dependent on the activation of the 
innate immune cells (macrophages, neutrophils, lymp-
hocytes and NK cells), synthesis and release of cytokines 
(TNF-α, IFN-α, IFN-γ, IL-1, IL-2, IL-6 and IL-8), 
generation of enhanced cell-mediated responses, and 
induction of nitric oxide production (Leung et al., 2004; 
Pugh et al., 2001; Im et al., 2005; Boudreau and Beland, 
2006). Besides the role in cellular immunity, researchers 
also  found  that A. vera induces antibody responses. The  
 




effects on antibody response were proved by the signifi-
cant increase in the number of B lymphocytes forming 
both IgM and IgG antibodies (Yates et al., 1992). The aim 
of this study was to evaluate the effect of A. vera admini-




MATERIALS AND METHODS 
 
Preparation of A. vera 
 
A. vera polysaccharides were prepared according to the method 
described by Wu et al. (2006). In brief, the leaves (300 g) of the 
plant, after blending in an electrical grinder, were extracted thrice 
with 2500 ml of distilled water at 70 to 80°C for 2 h. The filtrate of 
the obtained extract was condensed to syrup (ca. 500 ml), to which 
cold 95% ethanol (approximately 1500 ml) was added. The crude 
polysaccharide part was precipitated from the alcoholic liquor 
during its subsequent standing at 4°C overnight. The precipitate 
formed was collected by centrifugation at 12,000 x g and repeatedly 
washed sequentially with possibly less amounts of ethanol, acetone 
and ether, respectively. The refined crude polysaccharide (2.4 g) 
was re-dissolved in distilled water (240 ml) at a concentration of 1% 
(w/v) followed by filtration. The filtrate was deproteinized by treating 
it with trichloroacetic acid following the procedure detailed else-
where (Yang et al., 1999). After centrifugation at 12,000 x g for 10 
min, the supernatant was then precipitated with 3-fold volumes of 
95% ethanol to obtain the crude polysaccharides. 
 
 
Animal preparation and study design 
 
20 healthy male New Zealand white rabbits, weighing 2.0 to 2.5 kg, 
were used. The rabbits were kept for two weeks to adapt to the 
environmental conditions. They were housed in individual cages in 
a room with controlled temperature of 20 ± 22°C, and a 12 h 
light/dark cycle. The rabbits were fed standard diet and provided 
with fresh water ad libitum. Animals were randomly divided into five 
treatment groups (4 per group): Groups consisted of: 1) control 
group (normal saline, o.p.); 2) A. vera control o.p.; 3) vaccine 
control,;4) 50 mg A. vera extract o.p. + vaccine; 5) 150 mg A. vera 
extract o.p. + vaccine. The used vaccine was for myxomatosis 
(Mixohipra-FSA®, Laboratorios Hipra, S.A. one dose/rabbit). Blood 
samples were obtained from the central ear artery using 22 G 
catheter at four time points: days 0, 7, 14 and 21 of the study. Blood 
samples were transferred into heparinized and none heparinized 
tubes. Plasma was separated and stored frozen until assayed. For 
immunological analysis, the serum was separated by centrifugation 
at 3000 rpm/min for 10 min and stored at -20°C until analysis. 
 
 
Flow cytometric analysis 
 




 lymphocytes frequency, single cell 
suspensions were prepared by mechanical tissue disaggregation in 
cold PBS and centrifuged at 800 x g for 4 min. Cells were washed 
twice with PBS. We used unlabeled CD16/CD32 to rule out any 
non-specific antibody binding and included IgG controls for these 
three colors. Cell suspensions (about 10
6
 cells) were incubated with 
a mixture of the anti-CD4-PE-cy5 + anti-CD8-R-PE antibodies at 
4°C for 30 min in a dark environment; then cells were washed twice 
with PBS and suspended in PBS. The cells were analyzed using a 
flow cytometry (Beckman Coulter Epics XL-4). The data were 
analyzed using the System II version 3.0. About 20,000 lympho-







Serum immunglobulin (IgG, IgM and IgA) concentrations were 
measured by ELISA technique (Microplate Reader® - DAS) using 
commercial test kit for IgA, IgG and IgM (MCA630®, Serotec), 





Results were expressed as mean ± S.E.M. Multiple comparisons 
were performed by ANOVA followed by the Tukey honestly 
significant difference (HSD) test. In all the analyses, the level of 
















lymphocytes in the blood of rabbits in different groups. A. 
vera treatment produced a significant increase in the 
blood CD
4+
 after 14 and 21 days, respectively (P<0.05) 
and CD
8+
 lymphocytes after 7, 14 and 21 days (P<0.05), 
when compared with the control group. Therefore, A. vera 









Effect of A. vera polysaccharide on plasma IgM, IgG 
and IgA levels 
 
According to Table 2, serum IgM concentrations in 
groups 3, 4 and 5 increased inconsiderately (P<0.05) on 
days 7, 14 and 21 when compared to the control. Serum 
IgG concentrations in group 3 increased significantly only 
on day 14 (P<0.05), whereas its levels in group 4 and 5 
increased both on days 7, 14 and 21 (P<0.05). But serum 
IgG concentrations in groups 1 and 2 were not different 
significantly (P>0.05). There were no significant changes 






There are various indexes to evaluate the function of the 
immune system, for example, the composition of lympho-
cyte subsets and serum immunoglobulins are employed 
for the evaluation of the cellular and humoral immune 
responses, respectively. CD
4+
 cells are a type of white 
blood cell. White blood cells are important in fighting 
infections. A CD
4+
 count is a blood test to determine how 
well the immune system is working (Shirwan et al., 2003). 
CD
8+
 is a transmembrane glycoprotein that serves as a 
co-receptor for the T cell receptor (TCR). Like the TCR, 
CD
8+ 
 binds  to  a major histocompatibility complex (MHC)  
 








lymphocytes. The values are presented as mean ± SEM. 
 




0 69.3 ± 3.3 72.4 ± 3.2 69.4 ± 3.4 71.6 ± 3.8 72.2 ± 4.4 
7 71.4 ± 3.8 80.3 ± 4.6 71.6 ± 3.5 74.6 ± 3.5 75.5 ± 3.9 
14 72.1 ± 4.2 81.5 ± 4.2
a
 73.4 ± 4.3 80.8 ± 4.7
a
 88.4 ± 4.3
b
 
21 70.8 ± 3.7 89.2 ± 4.9
b
 72.7 ± .3.6 86.2 ± 4.6
b
 89.7 ± 4.6
b
 




0 48.3 ± 1.8 50.4 ± 1.9 48.7 ± 1.7 51.2 ± 2.1 50.8 ± 1.9 
7 50.1 ± 2.1 51.8 ± 2.2
a
 51.8 ± 2.5
a
 58.5 ± 2.3
b
 59.3 ± 2.7
b
 
14 48.8 ± 1.7 57.4 ± 1.7
b
 52.2 ± 2.3
a
 64.4 ± 2.5
c
 66.7 ± 2.5
c
 
21 49.3 ± 2.0 52.7 ± 1.8
a
 52.5 ± 2.4
a
 60.5 ± 2.3
b








Table 2. Effect of A. vera polysaccharide on plasma IgM, IgG and IgA levels. The values are presented as mean ± SEM. 
 
Ig Day G 1 G 2 G 3 G 4 G 5 
Ig M 
0 154.4 ± 3.2 158.5 ± 2.8 160.6 ± 3.6 157.6 ± 3.1 159.1 ± 2.9 
7 161.5 ± 3.3 156.4 ± 3.0 188.4 ± 3.7
a
 192.2 ± 3.5
a
 189.4 ± 3.7
a
 
14 158.7 ± 2.7 160.6 ± 3.1 205.7 ± 3.8
b
 210.5 ± 4.1
c
 212.4 ± 4.3
c
 
21 156.2 ± 2.8 157.3 ± 2.2 187.3 ± 3.4
a
 205.2 ± 3.8
b
 208.7 ± 3.8
bc
 
       
Ig G 
0 987.6 ± 9.8 992.7 ± 10.4 1067.5 ± 12.2 1024.8 ± 11.7 997.4 ± 10.6 
7 1032.8 ± 11.6 1052.4 ± 9.8 989.6 ± 8.6 1273.4 ± 11.8
a
 1267.5 ± 12.5
a
 
14 1067.4 ± 11.3 1073.9 ± 10.7 1248.3 ± 12.6
a
 1481.5 ± 13.8
b
 1563.3 ± 15.3
c
 
21 996.3 ± 9.9 1098.5 ± 11.3 1182.7 ± 10.8 1287.8 ± 11.3
a
 1446.9 ± 11.7
b
 
       
Ig A 
0 48.23 ± 4.3 49.65 ± 3.8 48.66 ± 5.2 50.35 ± 4.9 52.87 ± 5.4 
7 51.32 ± 3.8 52.74 ± 4.6 49.54 ± 5.1 50.23 ± 4.8 51.82 ± 4.4 
14 50.71 ± 3.9 50.98 ± 3.8 49.88 ± 4.7 48.75 ± 5.3 49.69 ± 3.9 
21 50.42 ± 4.2 50.65 ± 4.4 48.74 ± 3.7 50.44 ± 5.1 50.75 ± 5.2 
 




molecule, but it is specific for the class I MHC protein. It 
is predominantly expressed on the surface of cytotoxic T 
cells, but can also be found on natural killer cells 
(Vecchione et al., 2002). In previous experimental studies, 
increase or stimulation in CD
4+
, CD8 T lymphocytes and 
IgG concentrations were related to administration of A. 
vera (Hanaue et al., 1989; Yates et al., 1992; Leung et 
al., 2004; Sampedro et al., 2004; Boudreau and Beland, 
2006). Similarly, in this study, CD
4+
 T lymphocytes on 
days 14 and 21 and CD
8+
 T lymphocytes on days 7, 14 
and 21 increased in the study groups. Serum IgG and 
IgM concentrations on days 7, 14 and 21 AV increased in 
the study groups too. Immunostimulating action of A. Vera 
was reported to be induced by potentiation of synthesis 
and release of several cytokines such as TNF-α, IFN-γ, 
IL-1, IL-2 and IL-6 (Yates et al., 1992; Qiu et al., 2000; 
Leung et al., 2004; Im et al., 2005; Boudreau and Beland, 
2006). Moreover, it has been shown that A. vera derived 
polyglucans significantly supported the formation of 
specific  and  nonspecific  antibodies   (Im   et   al.,  2005; 
Boudreau and Beland, 2006). For this reason, increase in 
serum IgG after application of A. vera may be attributed 
to elevation in humoral immune response due to increase 
in both CD
4+
 T lymphocyte and cytokines synthesis or 
release. All lymphocyte subsets ratios and serum 
immunoglobulin concentrations except for IgA, increased 





lymphocyte, serum IgG and IgM concentrations increased 





 T lymphocytes, and serum IgG and IgM con-
centrations may be attributed to modulatory or stimulatory 
effects which suggest the effects of A. vera on both 
cellular and humoral immune response following vacci-
nation. Similar observations on immune system by A. 
vera have also been reported (Hanaue et al., 1989; 




 T lymphocyte is completely related to cellular 
immune response, while CD
4+
 T lymphocyte takes part in 
both  cellular  and  humoral  immune   responses.  CD
4+
 T  
 




lymphocytes according to cytokines that they release are 
divided into Th1 and Th2 cells. Antigenic stimulation of 
Th1 cells induce T cell cytotoxicity and macrophage 
activation through release of cytokines like IL-2, IFN-γ 
and TNF-β and also in the stimulation of Th2 cells and 
production of B cells. Th2 cells plays role in the 
stimulation of IL-4, IL-5, IL-10 and IL-13 cytokines leading 
to production of B cells and antibodies 43-45. The find-
ings relating to lymphocyte subsets confirm the findings 
of other studies where A. vera was used (Chinnah et al., 
1992; Boudreau and Beland, 2006). Our results showed 
that serum IgM, serum IgG and IgM concentrations in 
post vaccination period in the study increased as 
reported by researchers (Boudreau and Beland, 2006; 
Chinnah et al., 1992; Im et al., 2005; Pugh et al., 2001). 
On the other hand, the authors’ results on the evaluation 
of the effects of A. vera on antibody response in labo-
ratory animals showed that their potential to increase 
antibody response was present only when they were 
used as adjuvant (Yates et al., 1992; Chinnah et al., 
1992). These findings demonstrate that A. vera may 
stimulate humoral immune response as reported by some 
researchers (Leung et al., 2004; Sampedro et al., 2004; 
Im et al., 2005). 
In conclusion, this study demonstrated that oral admini-
stration of A. vera affects various aspects of the immune 
system, including the effects on the composition of 
lymphocyte subsets and serum immunoglobulins. These 
findings demonstrate that A. vera extract may stimulate 
both cellular and humoral immune responses after 
immunization. The observed changes after administration 
of A. Vera extract following immunization might occur 
with similar mechanisms. However, since exact mecha-
nisms of the stimulation of cell-mediated and humoral 
immunity related to A. vera application after vaccination 
still remain unknown, further investigations might be 
useful to understand the stimulatory mechanisms through 
investigation of Th1 and Th2 helper cells ratios, and 
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